Sharei Armon 4
4 · SQZ Biotechnologies Co · Filed Jan 12, 2021
Insider Transaction Report
Form 4
Sharei Armon
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2021-01-08$1.81/sh+2,500$4,525→ 251,713 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-08−2,500→ 203,986 totalExercise: $1.81Exp: 2026-10-10→ Common Stock (2,500 underlying)
Footnotes (2)
- [F1]Options were exercised and held for tax planning purposes.
- [F2]The option was originally granted for 286,514 shares. The option vested and and became exercisable as to the original share amount as to 25% of the underlying securities on October 11, 2017 and in 36 equal monthly installments thereafter.